Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Leukapheresis × Clear all

NCT06236139 2026-02-17

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

Prostatic Neoplasms